Independent forecasts built on public federal data. Not a U.S. government website.

PROGRESSIVE MEDICAL USA, INC

PROGRESSIVE MEDICAL USA, INC has won 15 federal awards worth $123K in total across 3 agencies, with a median award of $9K. See where they win and what those contracts close for, and forecast the price on a solicitation you're competing for.

15
awards won
$123K
total obligated
$9K
median award
3
agencies

Recent awards

TitleAgencyValueDate
WOUND VAC AND SUPPLIES OPTION YEAR 3 PERIOD OF PERFORMANCE: JULY 1, 2Department Of Justice$10K2025-06-10
WOUND VAC AND SUPPLIES DOS: OCTOBER 1 TO DECEMBER 31, 2024Department Of Justice$10K2024-09-11
NEGATIVE PRESSRE WOUND THERAPY SYSTEM & SUPPLIESDepartment Of Justice$10K2024-07-10
NEGATIVE PRESSRE WOUND THERAPY SYSTEM & SUPPLIESDepartment Of Justice$6K2023-07-07
NEGATIVE PRESSURE WOUND THERAPY SYSTEM EQUIPMENT & SUPPLIES PER BPA 15Department Of Justice$14K2022-09-22

Questions

How many federal contracts has PROGRESSIVE MEDICAL USA, INC won?

15 awards on record, worth $123K in total across 3 agencies. The median award is $9K.

Which agencies buy from PROGRESSIVE MEDICAL USA, INC?

Mostly Department Of Justice, Department Of Veterans Affairs.

Is PROGRESSIVE MEDICAL USA, INC a competitor worth watching?

That depends on your category. This page lists the agencies they win from and their recent awards, so you can see whether they are active in the lanes you bid. AwardCast forecasts the closing price for a specific open solicitation, which is the number that matters when you are bidding against them.

Agencies they win from

10 more awards + the price forecast for any solicitation this contractor is bidding.

Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.

Every forecast is scored against the real award once it becomes public. See the track record.

Get a forecast — $49

$49 per report. No subscription, no account needed to see pricing.